Scholz I, Montoya C, Vela E. Examination of vesicular stomatitis virus-induced morphology changes in individual Vero cells by QMod microscopy. BioTechniques 68: 00-00 (June 2020) 10.2144/btn-2019-0137
Scholz I, Montoya C, Vela E. Examination of vesicular stomatitis virus-induced morphology changes in individual Vero cells by QMod microscopy. BioTechniques 68: 00-00 (June 2020) 10.2144/btn-2019-0137
COVID-19 LetterPlease read the letter from our CEO regarding the precautionary measures we are taking at Ology Bioservices.
March 16, 2020
Dear Friends of Ology Bioservices:
These are unprecedented times as we respond to avoid the spread of COVID-19, a novel coronavirus that has challenged our routine life. First and foremost, all of us at Ology Bioservices, Inc. hope you and your family members are well, healthy, and safe from harm’s way.
I am reaching out to inform you of steps we are taking to protect our staff, operations and importantly, your ongoing projects at Ology Bio during this time. Our goal is to be prepared to continue serving our clients during this time of uncertainty and confusion. In order to protect our employees and facility, and to keep your projects moving forward, we have implemented the following activities:
There will be no disruption in communicating with Ology Bio personnel, and our offices will remain open. However, the limited number of personnel physically at our locations will mainly consist of those involved in supporting the process development and manufacturing of our customer’s biological products. Be assured that you will be able to reach all employees through their direct phone lines and email regardless of their location during this crisis.
The entire leadership team at Ology Bioservices remain committed to the health and safety of our employees and our commitments to the customers we serve. This nation has a history of strength and resilience and I am certain that together we will successfully navigate these challenges.
Sincerely,
Peter H. Khoury
President & CEO